Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNippon Active . Regulatory News (NAVF)

Share Price Information for Nippon Active . (NAVF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 172.00
Bid: 170.50
Ask: 172.00
Change: 0.50 (0.29%)
Spread: 1.50 (0.88%)
Open: 172.00
High: 173.00
Low: 172.00
Prev. Close: 171.50
NAVF Live PriceLast checked at -
Nippon Active Value is an Investment Trust

To provide Shareholders with attractive capital growth through the active management of a focussed portfolio of quoted companies which have the majority of their operations in, or revenue derived from, Japan and that have been identified by the Investment Adviser as being undervalued.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AJG Publication of Circular

12 Sep 2023 07:01

RNS Number : 0766M
Nippon Active Value Fund PLC
12 September 2023
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG, SINGAPORE OR THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL.

12 September 2023

Nippon Active Value Fund plc

LEI: 213800JOFEGZJYS21P75

AJG publication of Circular

Further to the Company's announcement dated 11 August 2023, which detailed proposals relating to the rollover of assets of each of abrdn Japan Investment Trust plc ("AJIT") and Atlantis Japan Growth Fund Limited ("AJG") into the Company pursuant to schemes of reconstruction of AJIT and AJG (respectively the "AJIT Scheme" and the "AJG Scheme", and together the "Schemes"), the Company notes the announcement today by AJG that it has published a shareholder circular (the "Circular") setting out proposals for the AJG Scheme.

The Board welcomes this news and believes that the Schemes offer a number of benefits, including an enlarged capital base over which to spread costs, potential for greater liquidity and a more diverse portfolio of assets. The timetable for the Scheme is as follows:

Expected Timetable[1]

2023

AJG Scheme Calculation Date

5.00 p.m. on 6 October

AJG General Meeting

3.00 p.m. on 10 October

Effective Date for implementation of the AJG Scheme

10 October

Announcement of results of the AJG Scheme and respective FAVs per share

10 October

Admission of the Ordinary Shares pursuant to the AJG Scheme

8.00 a.m. on 11 October

CREST accounts credited in respect of Ordinary Shares issued in uncertificated form

8.00 a.m. on 11 October

Certificates despatched in respect of New NAVF Shares during or as soon as practicable after

week commencing 16 October

[1] Note: All references to time in this document are to UK time. Each of the times and dates in the above expected timetable (other than in relation to the Extraordinary General Meeting) may be extended or brought forward. If any of the above times and/or dates change, the revised time(s) and/or date(s) will be notified to Shareholders by an announcement through a Regulatory Information Service.

 

Enquiries

Berenberg

Gillian Martin / Dan Gee-Summons / Natasha Ninkov Tel: +44 (0)20 3207 7800

 

Company Secretary

Maria Matheou Tel: +44 (0) 20 3327 9720

 

Important information relating to Sponsor and Financial Adviser

Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg") which is authorised and regulated by the German Federal Financial Supervisory Authority and deemed authorised and subject to limited regulation in the United Kingdom by the FCA, is acting solely as sponsor and financial adviser to the Company and for no one else in relation to the proposed transaction, and will not be responsible to anyone other than the Company for providing the protections afforded to the clients of Berenberg or for providing advice in relation to the proposed transaction, the contents of this document or any other matters described in this announcement.

Apart from the responsibilities and liabilities, if any, which may be imposed upon Berenberg by FSMA or the regulatory regime established thereunder, Berenberg does not accept any responsibility whatsoever or make any representation or warranty, express or implied, concerning the contents of this announcement, including as to its accuracy, completeness or verification, or for any other statement made or purported to be made by it, or on its behalf, in connection with the Company or the proposed transaction, whether as to the past or future.

 


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CIRMZGMLNMRGFZM
Date   Source Headline
9th May 20241:33 pmRNSNet Asset Value(s)
8th May 202412:00 pmRNSNet Asset Value(s)
7th May 202412:00 pmRNSNet Asset Value(s)
3rd May 202412:00 pmRNSNet Asset Value(s)
2nd May 202412:00 pmRNSNet Asset Value(s)
1st May 202412:00 pmRNSNet Asset Value(s)
30th Apr 202412:00 pmRNSNet Asset Value(s)
29th Apr 202412:00 pmRNSNet Asset Value(s)
26th Apr 202412:00 pmRNSNet Asset Value(s)
25th Apr 202412:00 pmRNSNet Asset Value(s)
24th Apr 202412:00 pmRNSNet Asset Value(s)
23rd Apr 202412:00 pmRNSNet Asset Value(s)
22nd Apr 202412:00 pmRNSNet Asset Value(s)
19th Apr 202412:18 pmRNSNet Asset Value(s)
18th Apr 202411:49 amRNSNet Asset Value(s)
17th Apr 202412:00 pmRNSNet Asset Value(s)
16th Apr 202412:00 pmRNSNet Asset Value(s)
15th Apr 202412:00 pmRNSNet Asset Value(s)
12th Apr 202412:30 pmRNSNet Asset Value(s)
11th Apr 202412:00 pmRNSNet Asset Value(s)
10th Apr 202411:00 amRNSNet Asset Value(s)
9th Apr 202412:00 pmRNSNet Asset Value(s)
9th Apr 202411:20 amRNSMonthly Factsheet
9th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 202412:00 pmRNSNet Asset Value(s)
5th Apr 202412:00 pmRNSNet Asset Value(s)
4th Apr 202412:00 pmRNSNet Asset Value(s)
3rd Apr 202412:00 pmRNSNet Asset Value(s)
3rd Apr 20247:01 amRNSDividend Declaration
3rd Apr 20247:00 amRNSFinal Results
2nd Apr 202412:20 pmRNSNet Asset Value(s)
28th Mar 202410:42 amRNSNet Asset Value(s)
27th Mar 202412:00 pmRNSNet Asset Value(s)
26th Mar 202412:00 pmRNSNet Asset Value(s)
25th Mar 202410:41 amRNSNet Asset Value(s)
22nd Mar 202412:00 pmRNSNet Asset Value(s)
21st Mar 202412:00 pmRNSNet Asset Value(s)
20th Mar 202412:00 pmRNSNet Asset Value(s)
19th Mar 202412:00 pmRNSNet Asset Value(s)
18th Mar 202412:00 pmRNSNet Asset Value(s)
15th Mar 202412:00 pmRNSNet Asset Value(s)
14th Mar 202412:00 pmRNSNet Asset Value(s)
13th Mar 202412:00 pmRNSNet Asset Value(s)
12th Mar 20244:38 pmRNSMonthly Factsheet
12th Mar 202412:00 pmRNSNet Asset Value(s)
11th Mar 202412:00 pmRNSNet Asset Value(s)
8th Mar 202412:00 pmRNSNet Asset Value(s)
7th Mar 202412:00 pmRNSNet Asset Value(s)
6th Mar 20242:00 pmRNSNet Asset Value(s)
5th Mar 202412:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.